.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 6,132,766

« Back to Dashboard

Summary for Patent: 6,132,766

Title: Multivesicular liposomes with controlled release of encapsulated biologically active substances
Abstract:A multivesicular liposome composition containing at least one acid other than a hydrohalic acid and at least one biologically active substance, the vesicles having defined size distribution, adjustable average size, internal chamber size and number, provides a controlled release rate of the biologically active substance from the composition. A process for making the composition features addition of a non-hydrohalic acid effective to sustain and control the rate of release of an encapsulated biologically active substance from the vesicles at therapeutic levels in vivo.
Inventor(s): Sankaram; Mantripragada Bhima (San Diego, CA), Kim; Sinil (Solana Beach, CA)
Assignee: SkyePharma Inc. (San Diego, CA)
Application Number:09/045,236
Patent Claim Types:
see list of patent claims
Use; Dosage form; Device;
Patent Metrics:
Source: PatentQuant.com
Field: Not categorized
Back Citations: 26th percentile
Forward Citations: 2nd percentile
Patent PDF download available with subscription

No matches for this query

International Patent Family for Patent: 6,132,766

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria196248<disabled in preview>
Australia1053595<disabled in preview>
Australia686277<disabled in preview>
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc